SPT suppressed tumor growth and prolonged the survival of host mice in 2 enzalutamide-resistant models, LuCaP 35CR-ENZR and LuCaP 96CR-ENZR (68), and SSTR1 expression increased after SPT in both models (Figure 7, F and G). The gene discussed is SSTR1; the disease is neoplasm.